Deep Learning-Based Early Warning Score for Predicting Clinical Deterioration in General Ward Cancer Patients.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Three-GRU deep-learning EWS used hourly vital signs plus consecutive-measurement deltas; retrospective Samsung cohort 2016–2020 and held-out 2020 set showed V2 AUROC .898 vs MEWS .588 for deterioration. Single-center temporal split, no external prospective validation.
Technology: Three-GRU deep-learning EWS used hourly vital signs plus consecutive-measurement deltas; retrospective Samsung cohort 2016–2020 and held-out 2020 set showed V2 AUROC .898 vs MEWS .588 for deterioration. Single-center temporal split, no external prospective validation.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Three-GRU deep-learning EWS used hourly vital signs plus consecutive-measurement deltas; retrospective Samsung cohort 2016–2020 and held-out 2020 set showed V2 AUROC .898 vs MEWS .588 for deterioration. Single-center temporal split, no external prospective validation.
- Limitation / still unknown
- Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.mdpi.com/2072-6694/15/21/5145
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.